https://www.avient.com/sites/default/files/2022-04/Avient Acquisition of Dyneema and Q1 2022 Results_0.pdf
Avient acquired the Clariant Color business on July 1, 2020 (the “Acquisition Date”).
To provide comparable financial results, the Company references “pro forma” financial metrics, which include the business results of Clariant Color for periods prior to the Acquisition Date.
As presented in previous slides, this presents potential benefits with respect to leverage and EBITDA margins Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/resources-0?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=20
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets
https://www.avient.com/sites/default/files/AVNT Q1 2023 Earnings Press Release.pdf
This includes increasing customer and employee engagement, optimizing our cost structure by capturing additional synergies from the Clariant acquisition, and minimizing working capital.”
The presentations will do a deep dive on the eight ways we approach sustainability, which include lightweighting, reduced energy use, sustainable infrastructure and human health & safety, to name a few.”
Rose Vice President, Marketing and Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com mailto:giuseppe.disalvo@avient.com mailto:kyle.rose@avient.com 7 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended March 31, 2023 2022 Sales $ 845.7 $ 892.2 Operating Income 57.1 102.2 Net income from continuing operations attributable to Avient shareholders 20.8 64.4 Basic earnings per share from continuing operations attributable to Avient shareholders $ 0.23 $ 0.70 Diluted earnings per share from continuing operations attributable to Avient shareholders $ 0.23 $ 0.70 Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for Switzerland.pdf
Buyer acknowledges that information in Seller’s marketing materials, technical data sheets and other descriptive publications distributed or published on its websites may vary from time to time without notice.
Buyer acknowledges that Seller has furnished to Buyer safety data sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.
Confidentiality and Data Protection.
https://www.avient.com/resources-0?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=6
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets
https://www.avient.com/products/polymer-colorants
Mevopur™ Healthcare Bio-based Polymer Solutions
Mevopur™ Healthcare Colorants and Formulations
Find
Technical Data Sheets
See List
https://www.avient.com/sites/default/files/2023-05/AVNT Q1 2023 Earnings Presentation.pdf
Additionally, Adjusted EPS excludes the impact of special items and amortization expense associated with intangible assets. 2 Keeping Safety First o Relentless focus on best-in-class safety performance as an ACC Responsible Care® organization Exceeding Customer Expectations o Complementary technologies and customer relationships offer opportunity for future revenue synergies o Proven innovation-led commercial strategy with strong brands and participation across the full value chain Collaboration in Innovation o Leveraging Dyneema®, the world’s strongest fiber™, to accelerate growth of sustainable, ultralight and high performance applications People – Culture is Everything o Talented, passionate and collaborative associates drive an effective integration strategy o Strong Great Places to Work® scores reflect positive integration efforts in first year AVIENT PROTECTIVE MATERIALS INTEGRATION 3 AVIENT PROTECTIVE MATERIALS K E Y I N D U S T R I E S PERSONAL PROTECTION Military • Law Enforcement • First Responders • Body Armor • Helmets • Vehicle Protection 50% MARINE & SUSTAINABLE INFRASTRUCTURE Towing / Mooring • Aquaculture • Floating Wind • Offshore Cranes 30% CONSUMER Consumer • Outdoor High Performance • Safety Equipment 20% 4 Figures reflect approximate proportions of 2022 sales Q 1 P ER FO RM A N CE Q1 2023 PERFORMANCE VS.
Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 32 79 87 83 81 76 73 90 79 77 76 73 69 60 22 A vi en t K W R P P G F U L A V Y R P M F M C C E H X L A S H E C L H U N E M N S C L MULTIPLE EXPANSION Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of April 28, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.51.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 33 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.9 14.6 13.7 13.0 11.9 8.8 18.7 17.4 11.8 10.0 9.7 9.1 8.0 7.9 A vi en t (2 01 1) A vi en t (2 01 8) A vi en t (2 02 3) K W R P P G R P M A V Y F U L E C L H X L F M C A S H S C L C E E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/products/polymer-additives/healthcare-additives
Mevopur™ Healthcare Functional Additives
Mevopur™ Healthcare Functional Additives
Mevopur™ Bio-based Polymer Solutions
https://www.avient.com/industries/healthcare/remote-monitoring-wearables/continuous-glucose-monitors-cgm
Mevopur™ Healthcare Functional Additives
Mevopur™ Healthcare Colorants and Formulations
Mevopur™ Healthcare Bio-based Polymer Solutions
https://www.avient.com/investor-center/news/polyone-announces-fourth-quarter-and-full-year-2019-results
Clariant
In millions, except per share data)
Condensed Consolidated Balance Sheets (Unaudited)